MetaVia Inc.
MTVA · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Browne Sarah Kaplan: Form 4
Insider disclosure · Filed · Report period 12 Oct 2026
-
Form 3
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001638287 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- MTVA on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 545 Concord Avenue, Suite 210, Cambridge, MA, 02138
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- NeuroBo Pharmaceuticals, Inc. (to 18 Nov 2024), Gemphire Therapeutics Inc. (to 31 Dec 2019)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields